BeStock  
Stocks › Biotechnology › PBYI

Puma Biotechnology PBYI

US equityMarket cap rank #3746Biotechnology
$9.60 −$0.22 (-2.19%)
Market open · Oct 8, 10:00 am ET · After hours $9.81 0.00%
Open$9.75
Prev close$9.81
Day range$9.59 – $9.75
Volume19.4K
Market cap$495.29M
P/E (TTM)18.8
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong uptrend

6 bullish · 1 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average+0.3%BullishTrading above the 20-day average of $9.57
Price vs 50-day average+5.0%BullishTrading above the 50-day average of $9.13
Price vs 200-day average+27.4%BullishTrading above the 200-day average of $7.53
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)56.7BullishMomentum leans positive
MACD (12,26,9)0.16BearishMACD line is below its signal line
Bollinger band position53%BullishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$9.57+0.3%
50-day SMA$9.13+5.0%
200-day SMA$7.53+27.4%

Recent price levels

LevelPrice
20-day high$10.10
20-day low$8.90
60-day high$10.10
60-day low$7.41
Upper Bollinger band$10.09
Lower Bollinger band$9.04

The 50-day average is currently 21.3% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility37.7%
Average true range4.39% of price
Max drawdown (1y)-25.8%
Volume (10d vs 90d)1.10x

Discussion

No comments yet — be the first to weigh in on PBYI.

Leave a comment

Scroll to Top